Periodic Reporting for period 3 - UNLEASHAD (Unleashing the curative potential of cancer immunotherapy)

TILT Biotherapeutics is developing a breakthrough oncolytic immunotherapy treatment for cancer. Advanced solid tumors are currently incurable and limited treatment options are available – preclinical data on TILT technology suggests curative potential. There are 10 million...